/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

ACUMEN PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.9 0.1029(10.29%) ABOS at 04 Dec 2025 04:24 PM Biotechnology
Lowest Today 1.79
Highest Today 1.9399
Today’s Open 1.79
Prev. Close 1.75
52 Week High 2.46
52 Week Low 0.86
Day’s Range: Low 1.79 High 1.9399
52-Week Range: Low 0.86 High 2.46
1 day return -
1 Week return +1.04
1 month return -0.51
3 month return +39.85
6 month return +83.8
1 year return -14.6
3 year return -65.53
5 year return -
10 year return -

Institutional Holdings

RA Capital Management, LLC 24.65

Sands Capital Ventures, LLC 5.64

Franklin Resources Inc 5.08

FMR Inc 3.35

Millennium Management LLC 3.22

Vanguard Group Inc 2.79

Knollwood Investment Advisory LLC 2.69

Franklin Biotechnology Discv A(acc)USD 2.44

Fidelity Select Health Care 1.88

Vanguard Total Stock Mkt Idx Inv 1.85

Pathstone Holdings LLC 1.75

Alyeska Investment Group, L.P. 1.55

ADAR1 Capital Management LLC 1.51

LAURION CAPITAL MANAGEMENT LP 1.43

Franklin Biotechnology Discovery A 1.36

Hudson Bay Capital Management LP 1.36

Franklin US Small Cap Growth Equity 1.27

Fidelity Advisor Health Care I 1.16

Two Sigma Advisers, LLC 0.70

Geode Capital Management, LLC 0.65

Goldman Sachs Group Inc 0.55

Vanguard Institutional Extnd Mkt Idx Tr 0.54

BlackRock Inc 0.48

Ikarian Capital, LLC 0.44

Y-Intercept (Hong Kong) Ltd 0.41

Renaissance Technologies Corp 0.41

A4Investments SICAV SIF ACCI IlanaA2EURH 0.37

Two Sigma Investments LLC 0.33

Fidelity VIP Health Care Initial 0.30

Fidelity Extended Market Index 0.28

Vifag 2002 SICAV 0.25

iShares Micro-Cap ETF 0.19

Bridgeway Ultra-Small Company Market 0.17

Fidelity Nasdaq Composite Index 0.11

Fidelity Total Market Index 0.10

Extended Equity Market Fund K 0.09

NT Col R2000 Val Idx Fd -DC -L -TierFour 0.08

Goldman Sachs Absolute Ret Trckr Instl 0.07

Fidelity Series Total Market Index 0.07

Spartan Extended Market Index Pool F 0.07

Market Status

Strong Buy: 5

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 106.00 M

PB Ratio 1.2222

PE Ratio 0.0

Enterprise Value 18.11 M

Total Assets 238.99 M

Volume 136211

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:1436000 1.4M, FY19:1697000 1.7M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:1436000 1.4M, FY19:1697000 1.7M

Annual Net worth FY23:-48740000 -48.7M, FY22:-40475000 -40.5M, FY21:-181679000 -181.7M, FY20:-7324000 -7.3M, FY19:-7862000 -7.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:-45000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-45000 -0.0M

Quarterly Net worth Q3/2025:-26451000 -26.5M, Q2/2025:-40950000 -41.0M, Q1/2025:-28796000 -28.8M, Q3/2024:-29765000 -29.8M, Q2/2024:-20537000 -20.5M

Fund house & investment objective

Company Information Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.

Organisation Biotechnology

Employees 61

Industry Biotechnology

CEO Mr. Daniel J. O'Connell M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow